Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma

Clinical Trial ID NCT00324155

PubWeight™ 118.61^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00324155

Top papers